Compare TXG & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TXG | MFIC |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance/Investors Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.1B |
| IPO Year | 2019 | 2004 |
| Metric | TXG | MFIC |
|---|---|---|
| Price | $15.58 | $11.93 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $14.96 | $12.96 |
| AVG Volume (30 Days) | ★ 2.6M | 576.4K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 12.75% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | ★ $641,814,000.00 | $324,678,000.00 |
| Revenue This Year | $4.50 | $9.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.16 |
| Revenue Growth | 1.92 | ★ 11.35 |
| 52 Week Low | $6.78 | $10.18 |
| 52 Week High | $20.34 | $14.74 |
| Indicator | TXG | MFIC |
|---|---|---|
| Relative Strength Index (RSI) | 42.57 | 48.43 |
| Support Level | $17.32 | $11.80 |
| Resistance Level | $18.38 | $12.02 |
| Average True Range (ATR) | 1.02 | 0.15 |
| MACD | -0.41 | -0.01 |
| Stochastic Oscillator | 1.94 | 33.63 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.